Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 107,105 | 97,800 | 96,042 | 88,183 | 91,140 |
| Cost of Goods | 6,593 | 4,263 | 7,165 | 5,028 | 4,949 |
| Gross Profit | 100,512 | 93,537 | 88,877 | 83,155 | 86,191 |
| Operating Expenses | 56,668 | 52,426 | 49,735 | 47,006 | 45,746 |
| Operating Income | 44,437 | 41,374 | 39,307 | 36,177 | 41,394 |
| Other Income | 6,695 | 6,593 | 7,468 | 7,420 | 7,216 |
| Pre-tax Income | 51,132 | 47,967 | 46,775 | 43,597 | 48,610 |
| Income Tax | -268 | -31,398 | 8,442 | 7,864 | 3,131 |
| Net Income Continuous | 51,400 | 79,365 | 38,333 | 35,733 | 45,479 |
| Net Income | $51,400 | $79,365 | $38,333 | $35,733 | $45,479 |
| EPS Basic Total Ops | 1.77 | 2.74 | 1.33 | 1.24 | 1.60 |
| EPS Basic Continuous Ops | 1.77 | 2.74 | 1.33 | 1.24 | 1.59 |
| EPS Diluted Total Ops | 1.69 | 2.66 | 1.29 | 1.20 | 1.53 |
| EPS Diluted Continuous Ops | 1.69 | 2.66 | 1.29 | 1.20 | 1.53 |
| EPS Diluted Before Non-Recurring Items | 1.70 | 2.66 | 1.29 | 1.20 | 1.52 |
| EBITDA(a) | $46,199 | $42,986 | $40,850 | $37,811 | $42,949 |